Immunome Inc (IMNM)

Cost of Revenue

$49.95M

TTM · Period ending: · USD

IMNM logo

IMNM Cost of Revenue

Latest reported$49.95M
IMNM TTM Cost of Revenue ($0.00 → $49.95M)
High-resolution chart · PNG

IMNM cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunome Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
49,946,000
50,666,000
49,913,000
49,913,000
720,000
0
0
0
166,000
5,882,000
9,795,000
9,795,000
9,629,000
3,913,000
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.